Product news

Share this article:

Quinnova Pharmaceuticals announced the commercial launch of Tersi Foam, (2.25% selenium sulfide) for the treatment of seborrheic dermatitis and tinea versicolor of the skin.

TopoTarget has announced that its Totect chemotherapy treatment has been approved by the FDA for marketing in the US. In October 2006, Totect was launched in Europe under the Savene brand. Totect is used as a therapy when anthracycline, intravenously administered, accidentally leaks into the surrounding healthy tissue. Anthracyclines are chemotherapeutic agents used to treat a large number of cancers including breast cancer and leukaemia.

The FDA has approved Ranbaxy Pharmaceuticals' version of carvedilol tablets, a beta blocker used to treat mild to severe heart failure. Total annual sales of the brand name equivalent of the drug, Coreg by GlaxoSmithKline, were $1.6 billion through June 2007, according to figures from IMS.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.